ANAPROX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Anaprox, and when can generic versions of Anaprox launch?
Anaprox is a drug marketed by Atnahs Pharma Us and is included in one NDA.
The generic ingredient in ANAPROX is naproxen sodium. There are forty-two drug master file entries for this compound. One hundred and thirty-four suppliers are listed for this compound. Additional details are available on the naproxen sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Anaprox
A generic version of ANAPROX was approved as naproxen sodium by CONTRACT PHARMACAL on January 13th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANAPROX?
- What are the global sales for ANAPROX?
- What is Average Wholesale Price for ANAPROX?
Summary for ANAPROX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 93 |
Clinical Trials: | 13 |
Patent Applications: | 6,692 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ANAPROX |
DailyMed Link: | ANAPROX at DailyMed |
![ANAPROX drug patent expirations Drug patent expirations by year for ANAPROX](/p/graph/s/t/ANAPROX-patent-expirations.png)
![Drug Prices for ANAPROX](/p/graph/drug-price/ANAPROX.png)
Recent Clinical Trials for ANAPROX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Northwestern Medical Group | Phase 2 |
Shirley Ryan AbilityLab | Phase 2 |
Apkar Apkarian | Phase 4 |
Pharmacology for ANAPROX
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for ANAPROX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Atnahs Pharma Us | ANAPROX | naproxen sodium | TABLET;ORAL | 018164-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Atnahs Pharma Us | ANAPROX DS | naproxen sodium | TABLET;ORAL | 018164-003 | Sep 30, 1987 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ANAPROX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Atnahs Pharma Us | ANAPROX | naproxen sodium | TABLET;ORAL | 018164-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Atnahs Pharma Us | ANAPROX | naproxen sodium | TABLET;ORAL | 018164-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Atnahs Pharma Us | ANAPROX | naproxen sodium | TABLET;ORAL | 018164-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ANAPROX
See the table below for patents covering ANAPROX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
France | 2035847 | ⤷ Sign Up | |
Germany | 1793825 | ⤷ Sign Up | |
Belgium | 734275 | ⤷ Sign Up | |
United Kingdom | 1301456 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ANAPROX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1411900 | C300481 | Netherlands | ⤷ Sign Up | PRODUCT NAME: NAPROXEN EN ESOMEPRAZOL; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17901/0263-001 20101105 |
1411900 | 2011C/016 | Belgium | ⤷ Sign Up | PRODUCT NAME: NAPROXENE ET ESOMEPRAZOLE (SOUS LA FORME D'ESOMEPRAZOLE MAGNESIUM TRIHYDRATE); AUTHORISATION NUMBER AND DATE: BE382505 20101214 |
0984957 | SPC/GB11/013 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
1411900 | SPC/GB11/015 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |